List of articles in "Drug" category - Page 24

Norvinisterone is a synthetic progestogen.

Lanicemine (AZD6765) is an NMDA antagonist developed by AstraZeneca which was being studied for the management of severe and treatment-resistant depression. It was originally developed as a neuroprotective agent but […]

4-Fluoroethcathinone is a substituted cathinone and structural analog of flephedrone (4-fluoromethcathinone). Its effects have not yet been fully characterized.

Dextromethorphan/quinidine (trade name Nuedexta) is a combination drug containing dextromethorphan and the class I antiarrhythmic agent quinidine. It is the first FDA-approved drug for the treatment of pseudobulbar affect (PBA).

Trametinib (trade name Mekinist) is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity.It inhibits MEK1 and MEK2.Trametinib had good results for metastatic melanoma carrying the BRAF […]

Alipogene tiparvovec (marketed under the trade name Glybera) is a gene therapy treatment that compensates for lipoprotein lipase deficiency (LPLD) which can cause severe pancreatitis. In July 2012 the European […]

Levamlodipine (INN) also known as levoamlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine. Amlodipine belongs to the dihydropyridine group of calcium channel blocker used as an antihypertensive and […]

LY-235959 is a competitive antagonist at the NMDA receptor. It has analgesic and neuroprotective effects and causes hypothermia in animal models as well as reducing the development of tolerance to […]

1-Phenylethylpiperidylidene-2-(4-chlorophenyl)sulfonamide (W-15) is a potent μ-opioid agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs.

STS-135 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide) is a designer drug offered by online vendors as a cannabimimetic agent. The structure of STS-135 appears to utilise an understanding of structure-activity relationships within the indole class […]